1/16
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
When does breast cancer screening start
age 45-54, yearly mammogram
When does colorectal cancer screening start
45, stool tests or colonoscopy
When does lung cancer screening start
50-80 if smoker or hx of 20 pack years
Pack years
Packs per day X Years smoked
Carcinoma | |
Leukemia | |
Lymphoma | |
Sarcoma | |
Multiple Myeloma |
Carcinoma | Epithelial cells |
Leukemia | Bone marrow |
Lymphoma | Lymphatic system |
Sarcoma | Connective tissue (muscle, bone, cartilage) |
Multiple Myeloma | Plasma cells fo bone marrow |
Drugs that target M phase of cell cycle (Mitosis)
Taxanes (Taxels)
Vinca Alkoids (cristines)
Drugs that target S phase of cell cycle (DNA replication)
Anitmetabolites- Methoxtrexate, 5FU, Capcitabine
Topoisomerase I inhibitors - Irinotecan, topotecan
Drugs that target G2 phase of cell cycle (Growth)
Etoposide
Bleomycin
Drugs do not target specific cell cycle
Alkylating agents- cyclophosphamide,
Anthracyclines- Doxarubicin
Platinum compounds- Cisplatin, carboplatin, oxiplatin
BSA Equation
Square root of (Ht cm x Wtkg)/3600
Chemo Man

Chemo Extravasation Management

Taxanes boxed warning and management |
Taxanes (eg, paclitaxel) have a boxed warning for hypersensitivity reactions and require premedication with a corticosteroid (eg, dexamethasone), histamine-1 receptor antagonist (eg, diphenhydramine), and histamine-2 receptor antagonist (eg, famotidine). |
Target cancer therapies
tu= tumors eg rituximab
ci- circulators eg bevacizumab
li= immune eg ipilimumab
Breast Cancer treatment
IF HR positive (ER or PR +) and pre menopausal—> Tamoxifen
IF HR positive (ER or PR +) and post menopausal—> Tamoxifen or anastrazole
IF HER2+—> Add traztuzumab or pertuzumab
IF triple negative—> Taxanes and anthracyclines, no hormone therapies
Prostate Cancer Algorithm
GnRH Agonist (Leuprolide, Goserelin) + Antiandrogen (-mide)
or
GNRH antagonists (Degarelix, Relugolix)
Tumor Lysis Syndrome Effects
Hyperkalemia
Hypocalcemia
Hyperuricemia
Acute renal Failure